The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development
Open accessAbstract
The highly conserved 14-3-3 protein family has risen to a position of importance in cell biology owing to its involvement in vital cellular processes, such as metabolism, protein trafficking, signal transduction, apoptosis and cell-cycle regulation. The 14-3-3 proteins are phospho-serine/phospho-threonine binding proteins that interact with a diverse array of binding partners. Because many 14-3-3 interactions are phosphorylation-dependent, 14-3-3 has been tightly integrated into the core phospho-regulatory pathways that are crucial for normal growth and development and that often become dysregulated in human disease states such as cancer. This review examines the recent advances that further elucidate the role of 14-3-3 proteins as integrators of diverse signaling cues that influence cell fate decisions and tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Wan, P. T. C., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Project, C. G., Jones, C. M., Marshall, C. J., Springer, C. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00215-6 · Cited by 2,808
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384
mTOR and cancer: insights into a complex relationship
Sabatini, D. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1974 · Cited by 1,322
YAP1 increases organ size and expands undifferentiated progenitor cells
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237 · cited 6×
“Also functioning upstream of TORC1 is the tuberous sclerosis complex TSC1–TSC2, which inhibits TORC1 signaling as a result of the GTPase-activating protein (GAP) activity that is intrinsic to TSC2 and that inactivates Rheb [19].”
BackgroundInfluentialPRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Sancak, Y., Thoreen, C. C., Peterson, T. R., Lindquist, R. A., Kang, S. A., Spooner, E., Carr, S. A., & Sabatini, D. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.03.003 · Cited by 1,236 · cited 10×
“With regard to PRAS40, 14-3-3 binding is mediated by pT246, a site phosphorylated by AKT [25,26].”
BackgroundInfluentialThe RAF proteins take centre stage
Wellbrock, C., Karasarides, M., & Marais, R. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1498 · Cited by 1,228
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40
Haar, E. V., Lee, S.-I., Bandhakavi, S., Griffin, T. J., & Kim, D.-H. (2007) · Nature Cell Biology · doi:10.1038/ncb1547 · Cited by 1,190
Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells
Fujiwara, T., Bandi, M., Nitta, M., Ivanova, E. V., Bronson, R. T., & Pellman, D. (2005) · Nature · doi:10.1038/nature04217 · Cited by 1,067
Lei, Q.-Y., Zhang, H., Zhao, B., Zha, Z.-Y., Bai, F., Pei, X.-H., Zhao, S., Xiong, Y., & Guan, K.-L. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01874-07 · Cited by 924
14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895
The many ways of Wnt in cancer
Polakis, P. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.007 · Cited by 866
14-3-3 proteins: A historic overview
Aitken, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.005 · Cited by 826
Bhaskar, P. T., & Hay, N. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.03.020 · Cited by 798
DeYoung, M. P., Horak, P., Sofer, A., Sgroi, D., & Ellisen, L. W. (2008) · Genes & Development · doi:10.1101/gad.1617608 · Cited by 710 · cited 2×
“A report by DeYoung and colleagues describes a mechanism for how expression of REDD1 might modulate TSC2 activity and this mechanism involves 14-3-3 [28].”
BackgroundHippo signaling in organ size control
Pan, D. (2007) · Genes & Development · doi:10.1101/gad.1536007 · Cited by 647
The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
Harvey, K., & Tapon, N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2070 · Cited by 628
JNK promotes Bax translocation to mitochondria through phosphorylation of 14‐3‐3 proteins
Tsuruta, F., Sunayama, J., Mori, Y., Hattori, S., Shimizu, S., Tsujimoto, Y., Yoshioka, K., Masuyama, N., & Gotoh, Y. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600194 · Cited by 556
Rheb fills a GAP between TSC and TOR
Manning, B. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.09.003 · Cited by 483
Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1
Sofer, A., Lei, K., Johannessen, C. M., & Ellisen, L. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5834-5845.2005 · Cited by 449
Zeng, Q., & Hong, W. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.011 · Cited by 435
Regulation and Role of Raf-1/B-Raf Heterodimerization
Rushworth, L. K., Hindley, A. D., O'Neill, E., & Kolch, W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2262-2272.2006 · Cited by 418
Wild-Type and Mutant B-RAF Activate C-RAF through Distinct Mechanisms Involving Heterodimerization
Garnett, M. J., Rana, S., Paterson, H., Barford, D., & Marais, R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.022 · Cited by 416
Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines
Shi, Q., & King, R. W. (2005) · Nature · doi:10.1038/nature03958 · Cited by 394
Saucedo, L. J., & Edgar, B. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2221 · Cited by 363
Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning
Cai, S.-L., Tee, A. R., Short, J. D., Bergeron, J. M., Kim, J., Shen, J., Guo, R., Johnson, C. L., Kiguchi, K., & Walker, C. L. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200507119 · Cited by 359
JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3
Sunayama, J., Tsuruta, F., Masuyama, N., & Gotoh, Y. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200409117 · Cited by 335
Laronga, C., Yang, H.-Y., Neal, C., & Lee, M.-H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m905616199 · Cited by 304
Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer
Umbricht, C. B., Evron, E., Gabrielson, E., Ferguson, A. T., Marks, J., & Sukumar, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204438 · Cited by 291
Gardino, A. K., Smerdon, S. J., & Yaffe, M. B. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.007 · Cited by 286
Chibby, a nuclear β-catenin-associated antagonist of the Wnt/Wingless pathway
Takemaru, K.-I., Yamaguchi, S., Lee, Y. S., Zhang, Y., Carthew, R. W., & Moon, R. T. (2003) · Nature · doi:10.1038/nature01570 · Cited by 274
Donovan, N., Becker, E. B. E., Konishi, Y., & Bonni, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206113200 · Cited by 254
Yoshida, K., Yamaguchi, T., Natsume, T., Kufe, D., & Miki, Y. (2005) · Nature Cell Biology · doi:10.1038/ncb1228 · Cited by 246
Corradetti, M. N., Inoki, K., & Guan, K.-L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c400557200 · Cited by 237
A Structural Basis for 14-3-3σ Functional Specificity*♦
Wilker, E. W., Grant, R. A., Artim, S. C., & Yaffe, M. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500982200 · Cited by 232
14-3-3 proteins as potential oncogenes
Tzivion, G., Gupta, V. S., Kaplun, L., & Balan, V. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.004 · Cited by 220
14-3-3σ controls mitotic translation to facilitate cytokinesis
Wilker, E. W., van Vugt, M. A. T. M., Artim, S. C., Huang, P. H., Petersen, C. P., Reinhardt, H. C., Feng, Y., Sharp, P. A., Sonenberg, N., White, F. M., et al. (2007) · Nature · doi:10.1038/nature05584 · Cited by 216
Activation of FOXO1 by Cdk1 in Cycling Cells and Postmitotic Neurons
Yuan, Z., Becker, E. B. E., Merlo, P., Yamada, T., DiBacco, S., Konishi, Y., Schaefer, E. M., & Bonni, A. (2008) · Science · doi:10.1126/science.1152337 · Cited by 190
Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways
Porter, G. W., Khuri, F. R., & Fu, H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.003 · Cited by 167
β‐Catenin signaling in biological control and cancer
Gavert, N., & Ben‐Ze'ev, A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21505 · Cited by 164
Li, Y., Inoki, K., Vacratsis, P., & Guan, K.-L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300862200 · Cited by 163
The Differential Proteome Profile of Stomach Cancer: Identification of the Biomarker Candidates
Jang, J. S. J., Cho, H. Y., Lee, Y. J., Ha, W. S., & Kim, H. W. (2004) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/0965040042380441 · Cited by 161
Chibby cooperates with 14-3-3 to regulate β-catenin subcellular distribution and signaling activity
Li, F., Mofunanya, A., Harris, K., & Takemaru, K. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200709091 · Cited by 147
Li, Z., Zhao, J., Du, Y., Park, H. R., Sun, S., Bernal‐Mizrachi, L., Aitken, A., Khuri, F. R., & Fu, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710905105 · Cited by 147
REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase
Schwarzer, R., Tondera, D., Arnold, W., Giese, K., Klippel, A., & Kaufmann, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208236 · Cited by 142
The regulated assembly of a PKCɛ complex controls the completion of cytokinesis
Saurin, A. T., Durgan, J., Cameron, A. J. M., Faisal, A., Marber, M. S., & Parker, P. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1749 · Cited by 134
Growth Control Under Stress: mTOR Regulation through the REDD1-TSC Pathway
Ellisen, L. W. (2005) · Cell Cycle · doi:10.4161/cc.4.11.2139 · Cited by 131
BRCA1 Is a Selective Co-activator of 14-3-3ς Gene Transcription in Mouse Embryonic Stem Cells
Aprelikova, O. N., Pace, A. J., Fang, B. S., Koller, B. H., & Liu, E. T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100265200 · Cited by 112
Regulation of TSC2 by 14-3-3 Binding
Li, Y., Inoki, K., Yeung, R. S. W., & Guan, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200510200 · Cited by 112
When 2+2=5: The origins and fates of aneuploid and tetraploid cells
King, R. W. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.07.007 · Cited by 109
Identification of differentially expressed genes in oral squamous cell carcinoma
Arora, S., Matta, A., Shukla, N. K., Deo, S. V. S., & Ralhan, R. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20048 · Cited by 106
Cellular functions of 14-3-3ζ in apoptosis and cell adhesion emphasize its oncogenic character
Niemantsverdriet, M., Wagner, K., Visser, M., & Backendorf, C. (2007) · Oncogene · doi:10.1038/sj.onc.1210742 · Cited by 88
Identification and Characterization of the Interaction between Tuberin and 14-3-3ζ
Nellist, M. D., Goedbloed, M., de Winter, C., Verhaaf, B., Jankie, A., Reuser, A. J. J., van den Ouweland, A. M. W., van der Sluijs, P., & Halley, D. J. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204802200 · Cited by 76
Shumway, S. D., Li, Y., & Xiong, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200499200 · Cited by 74
Epigenetic silencing of 14-3-3sigma in cancer
Lodygin, D., & Hermeking, H. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.008 · Cited by 69
Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer.
Ghadimi, Β. M., Grade, M., Liersch, T., Langer, C., Siemer, A., FÜZESI, L., & Becker, H. (2003) · PubMed · Cited by 65
Cited by
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases
Cargnello, M., & Roux, P. P. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-10 · Cited by 3,274
Targeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
FoxO transcription factors; Regulation by AKT and 14-3-3 proteins
Tzivion, G., Dobson, M., & Ramakrishnan, G. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.06.002 · Cited by 728
The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
Varelas, X. (2014) · Development · doi:10.1242/dev.102376 · Cited by 665
“Of note, TAZ/YAP cytoplasmic recruitment relies on binding to 14-3-3 proteins, which themselves have extended connections with a wide range of polarity regulators (Morrison, 2009).”
Background
Metadata
- Authors
- Morrison, D. K.
- Venue
- Trends in Cell Biology
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 19
- Issue
- 1
- Pages
- 16-23
- ISSN
- 0962-8924 (ISSN-L)
- OpenAlex
- W2050892986
- Cited by
- 605
- References
- 64
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.